Skip to main content
Erschienen in: Diabetology International 2/2017

01.11.2016 | Original Article

Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors

verfasst von: Yuko Murata, Yoshiki Kadoya, Shoichi Yamada, Tokio Sanke

Erschienen in: Diabetology International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Aim

Diabetes mellitus is reported to be a risk factor for dementia. We evaluated the cognitive function in elderly diabetic patients and estimated the prevalence of patients with cognitive impairment and looked for any related clinical factors.

Subjects and methods

Using 281 elderly (65 years of age or older) Japanese patients with type 2 diabetes mellitus who were free of clinically evident cognitive impairment, we evaluated their cognitive function with the Mini Mental State Examination (MMSE).

Results

The MMSE score of all the participants was 27.3 ± 2.4 with 31.3% of them being in the abnormal range (tentatively defined normal range as having an MMSE score of 27–30). Multiple regression analysis disclosed that fasting serum non-esterified fatty acid (NEFA), estimated glomerular filtration ratio (eGFR) and insulin treatment were significantly related factors for the MMSE score, in addition to age and schooling history, which are extremely strong factors.

Conclusions

We revealed that approximately one-third of elderly type 2 diabetic patients who were free of clinically evident cognitive impairment had impaired cognitive function, demonstrating that the MMSE score was significantly correlated with fasting NEFA level, renal function, insulin treatment, age and schooling history.
Literatur
1.
Zurück zum Zitat Blesseis GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.CrossRef Blesseis GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.CrossRef
2.
Zurück zum Zitat Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011;77:1126–34. Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011;77:1126–34.
3.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–96.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–96.CrossRefPubMed
4.
Zurück zum Zitat Anthony JC, LeResche L, Niaz U, et al. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397–408.CrossRefPubMed Anthony JC, LeResche L, Niaz U, et al. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397–408.CrossRefPubMed
5.
Zurück zum Zitat Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract. 2008;82:305–9.CrossRefPubMed Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract. 2008;82:305–9.CrossRefPubMed
6.
Zurück zum Zitat Yamazaki Y, Miwa T, Sakurai H, et al. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011;58:109–15.CrossRefPubMed Yamazaki Y, Miwa T, Sakurai H, et al. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011;58:109–15.CrossRefPubMed
7.
Zurück zum Zitat Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diab Res Clin Pract. 2014;106:465–73.CrossRef Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diab Res Clin Pract. 2014;106:465–73.CrossRef
8.
Zurück zum Zitat Starkstein SE, Rabins PV, Berthier ML, et al. Dementia of depression among patients with neurological disorders and functional depression. J Neuropsychiatry Clin Neurosci. 1989;1:263–8.CrossRefPubMed Starkstein SE, Rabins PV, Berthier ML, et al. Dementia of depression among patients with neurological disorders and functional depression. J Neuropsychiatry Clin Neurosci. 1989;1:263–8.CrossRefPubMed
9.
Zurück zum Zitat Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age Ageing. 1999;28:35–8.CrossRefPubMed Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age Ageing. 1999;28:35–8.CrossRefPubMed
10.
Zurück zum Zitat Crane PK, Walker R, Hubbard, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–8. Crane PK, Walker R, Hubbard, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–8.
11.
Zurück zum Zitat Rizzo MR, Marfella R, Barbieri M, et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33:2169–74. Rizzo MR, Marfella R, Barbieri M, et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33:2169–74.
12.
Zurück zum Zitat Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29:2688–93.CrossRefPubMed Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29:2688–93.CrossRefPubMed
13.
Zurück zum Zitat Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764–70.CrossRefPubMed Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764–70.CrossRefPubMed
14.
Zurück zum Zitat Li J, Wang YJ, Zhang M, et al. Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–91.CrossRefPubMed Li J, Wang YJ, Zhang M, et al. Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–91.CrossRefPubMed
15.
Zurück zum Zitat Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–80.CrossRefPubMed Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–80.CrossRefPubMed
16.
Zurück zum Zitat Kawamura T, Umemura T, Hotta M. Cognitive impairment in diabetic patients: can diabetes control prevent cognitive decline. J Diabetes Investig. 2012;10:413–23.CrossRef Kawamura T, Umemura T, Hotta M. Cognitive impairment in diabetic patients: can diabetes control prevent cognitive decline. J Diabetes Investig. 2012;10:413–23.CrossRef
17.
Zurück zum Zitat Kawamura T, Umemura T, Umegaki H, et al. Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: association with microinflammation. J Diabetes Investig. 2014;5:597–605.CrossRefPubMedPubMedCentral Kawamura T, Umemura T, Umegaki H, et al. Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: association with microinflammation. J Diabetes Investig. 2014;5:597–605.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Zhang JB, Geng N, Li ZG, et al. Biomarkers of renal function in type 2 diabetic patients with cognitive impairment. Neurosci Lett. 2016;610:19–23.CrossRefPubMed Zhang JB, Geng N, Li ZG, et al. Biomarkers of renal function in type 2 diabetic patients with cognitive impairment. Neurosci Lett. 2016;610:19–23.CrossRefPubMed
19.
Zurück zum Zitat Umegaki H, Iimuro S, Shinozaki T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12(Suppl 1):103–9. Umegaki H, Iimuro S, Shinozaki T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12(Suppl 1):103–9.
20.
Zurück zum Zitat Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.CrossRefPubMedPubMedCentral Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Feil DG, Rajan M, Soroka O, et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59:2263–72.CrossRefPubMed Feil DG, Rajan M, Soroka O, et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59:2263–72.CrossRefPubMed
22.
Zurück zum Zitat Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4:202–7.PubMed Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4:202–7.PubMed
23.
Zurück zum Zitat Snigdha S, Astarita G, Piomelli D, et al. Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience. 2012;202:326–33.CrossRefPubMed Snigdha S, Astarita G, Piomelli D, et al. Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience. 2012;202:326–33.CrossRefPubMed
24.
Zurück zum Zitat Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776–82.CrossRefPubMed Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776–82.CrossRefPubMed
25.
Zurück zum Zitat Page KA, Williamson A, Yu N, et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009;58:1237–44.CrossRefPubMedPubMedCentral Page KA, Williamson A, Yu N, et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009;58:1237–44.CrossRefPubMedPubMedCentral
Metadaten
Titel
Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors
verfasst von
Yuko Murata
Yoshiki Kadoya
Shoichi Yamada
Tokio Sanke
Publikationsdatum
01.11.2016
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 2/2017
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-016-0292-9

Weitere Artikel der Ausgabe 2/2017

Diabetology International 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.